Discounted Cash Flow Rating

Strong Sell

Return on Equity Rating

Strong Sell

Debt to Equity Rating

Strong Buy

Price to Earnings Rating

Buy

Analyst Rating

Neutral

Simple Moving Average

Neutral

Exponential Moving Average

Neutral

Relative Strength Index

Standard Deviation

Neutral

Williams %R

Strong Buy

Average Directional Index

Sell

Insider Trading

Neutral

Wall Street Data Solutions Rating

Neutral

B

Durect Corp (DRRX)

Pharmaceutical Preparations

https://www.durect.com

Durect Corp is a biopharmaceutical company. It is engaged in the research, development, and manufacturing of pharmaceutical products. The company develops pharmaceutical products based on two categories which include new chemical entities and proprietary pharmaceutical programs. The company's pipeline products consist of DUR-928, POSIMIR, and others. Geographically, the company operates in the United States, Europe, Japan, and other countries, of which key revenue is derived from the Europe .

10260 BUBB RD
CUPERTINO, CA

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

09/28/2000

Market Cap

35,229,719

Shares Outstanding

29,830,000

Weighted SO

29,828,891

Total Employees

N/A

Upcoming Earnings

08/14/2024

Similar Tickers

SHPH --.--%

MNK --.--%

ORGO --.--%

LSDI --.--%

ALIM --.--%

TKNO --.--%

AGRX --.--%

SNOA --.--%

EGRX --.--%

Beta

1.0330

Last Div

0.0000

Range

0.47-3.36

Chg

-0.0150

Avg Vol

147964

Mkt Cap

35229719

Exch

NASDAQ

Country

US

Phone

408 777 1417

DCF Diff

2.1543

DCF

-1.0143

Div Yield

0.0000

P/S

4.1885

EV Multiple

-1.4638

P/FV

6.9939

Div Yield %

0.0000

P/E

-2.2298

PEG

-0.0682

Payout

0.0000

Current Ratio

0.9098

Quick Ratio

0.7970

Cash Ratio

0.7135

DSO

43.9163

DIO

559.1393

Op Cycle

603.0556

DPO

89.0464

CCC

514.0092

Gross Margin

0.8080

Op Margin

-2.9642

Pretax Margin

-1.8784

Net Margin

-1.8784

Eff Tax Rate

0.0297

ROA

-0.5292

ROE

-1.4861

ROCE

-3.1456

NI/EBT

1.0000

EBT/EBIT

0.6337

EBIT/Rev

-2.9642

Debt Ratio

0.5381

D/E

3.1892

LT Debt/Cap

0.3059

Total Debt/Cap

0.7613

Int Coverage

-17.7959

CF/Debt

-1.6335

Equity Multi

5.9269

Rec Turnover

8.3113

Pay Turnover

4.0990

Inv Turnover

0.6528

FA Turnover

2.4330

Asset Turnover

0.2817

OCF/Share

-0.8454

FCF/Share

-0.8125

Cash/Share

0.5041

OCF/Sales

-3.1197

FCF/OCF

0.9611

CF Coverage

-1.6335

ST Coverage

-1.8954

CapEx Coverage

-25.7003

Div&CapEx Cov

-25.7003

P/BV

6.9939

P/B

6.9939

P/S

4.1885

P/E

-2.2298

P/FCF

-1.3970

P/OCF

-1.3425

P/CF

-1.3425

PEG

-0.0682

P/S

4.1885

EV Multiple

-1.4638

P/FV

6.9939

DPS

0.0000

Latest Headlines (EST)

No Headlines Found

Revenue Product Segmentation